Cefoxitin
CEFOXITIN FOR INJECTION, USP(For Intravenous Use)
Approved
Approval ID
b272ef9c-4d83-4ee2-b9cc-477440822cca
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jan 3, 2024
Manufacturers
FDA
Sagent Pharmaceuticals
DUNS: 080579617
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
cefoxitin
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code25021-109
Application NumberANDA065414
Product Classification
M
Marketing Category
C73584
G
Generic Name
cefoxitin
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateJanuary 3, 2024
FDA Product Classification
INGREDIENTS (1)
cefoxitin sodiumActive
Quantity: 1 g in 1 1
Code: Q68050H03T
Classification: ACTIM
cefoxitin
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code25021-110
Application NumberANDA065414
Product Classification
M
Marketing Category
C73584
G
Generic Name
cefoxitin
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateJanuary 3, 2024
FDA Product Classification
INGREDIENTS (1)
cefoxitin sodiumActive
Quantity: 2 g in 1 1
Code: Q68050H03T
Classification: ACTIM